I-Mab Files Q3 2024 Financial Results
Ticker: NBP · Form: 6-K · Filed: Nov 14, 2024 · CIK: 1778016
Sentiment: neutral
Topics: financial-results, 6-K, quarterly-report
TL;DR
I-Mab dropped its Q3 2024 earnings report on Nov 14th.
AI Summary
I-Mab announced its financial results for the three and nine months ended September 30, 2024, on November 14, 2024. The company, headquartered in Rockville, MD, is a foreign private issuer filing under the 1934 Act. This filing is a Form 6-K, which is used to report interim financial information.
Why It Matters
This filing provides investors with updated financial performance data for I-Mab, crucial for assessing the company's current financial health and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine financial results announcement and does not contain significant new risks.
Key Players & Entities
- I-Mab (company) — Registrant
- November 14, 2024 (date) — Date of announcement and filing
- September 30, 2024 (date) — End of reporting period
- Rockville, MD (location) — Company headquarters
- 001-39173 (other) — SEC File Number
FAQ
What type of filing is this Form 6-K?
This Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934.
What period do the financial results cover?
The financial results announced cover the three and nine months ended September 30, 2024.
When was this report filed?
This report was filed on November 14, 2024.
Where is I-Mab's principal executive office located?
I-Mab's principal executive offices are located at 2440 Research Boulevard, Suite 400, Rockville, MD 20850.
Does I-Mab file annual reports under Form 20-F or 40-F?
I-Mab indicates that it files annual reports under cover of Form 20-F.
Filing Stats: 283 words · 1 min read · ~1 pages · Grade level 9.8 · Accepted 2024-11-14 07:00:09
Filing Documents
- i_-_mab_6k_q3_2024.htm (6-K) — 25KB
- imab-ex99_1.htm (EX-99.1) — 320KB
- imab-ex99_2.htm (EX-99.2) — 39KB
- imab-ex99_2s1.jpg (GRAPHIC) — 187KB
- imab-ex99_2s2.jpg (GRAPHIC) — 867KB
- imab-ex99_2s3.jpg (GRAPHIC) — 240KB
- imab-ex99_2s4.jpg (GRAPHIC) — 379KB
- imab-ex99_2s5.jpg (GRAPHIC) — 270KB
- imab-ex99_2s6.jpg (GRAPHIC) — 342KB
- imab-ex99_2s7.jpg (GRAPHIC) — 414KB
- imab-ex99_2s8.jpg (GRAPHIC) — 322KB
- imab-ex99_2s9.jpg (GRAPHIC) — 325KB
- imab-ex99_2s10.jpg (GRAPHIC) — 377KB
- imab-ex99_2s11.jpg (GRAPHIC) — 245KB
- imab-ex99_2s12.jpg (GRAPHIC) — 326KB
- imab-ex99_2s13.jpg (GRAPHIC) — 335KB
- imab-ex99_2s14.jpg (GRAPHIC) — 337KB
- imab-ex99_2s15.jpg (GRAPHIC) — 310KB
- imab-ex99_2s16.jpg (GRAPHIC) — 467KB
- imab-ex99_2s17.jpg (GRAPHIC) — 442KB
- imab-ex99_2s18.jpg (GRAPHIC) — 401KB
- imab-ex99_2s19.jpg (GRAPHIC) — 419KB
- imab-ex99_2s20.jpg (GRAPHIC) — 331KB
- imab-ex99_2s21.jpg (GRAPHIC) — 478KB
- imab-ex99_2s22.jpg (GRAPHIC) — 329KB
- imab-ex99_2s23.jpg (GRAPHIC) — 412KB
- imab-ex99_2s24.jpg (GRAPHIC) — 376KB
- imab-ex99_2s25.jpg (GRAPHIC) — 348KB
- imab-ex99_2s26.jpg (GRAPHIC) — 377KB
- imab-ex99_2s27.jpg (GRAPHIC) — 208KB
- 0000950170-24-126726.txt ( ) — 13965KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. I-MAB By : /s/ Joseph Skelton Name : Joseph Skelton Title : Chief Financial Officer Date: November 14, 2024